These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9422364)

  • 1. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy.
    Mackic JB; Weiss MH; Miao W; Kirkman E; Ghiso J; Calero M; Bading J; Frangione B; Zlokovic BV
    J Neurochem; 1998 Jan; 70(1):210-5. PubMed ID: 9422364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions.
    Mackic JB; Bading J; Ghiso J; Walker L; Wisniewski T; Frangione B; Zlokovic BV
    Vascul Pharmacol; 2002 Jun; 38(6):303-13. PubMed ID: 12529925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta.
    Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV
    J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain clearance of Alzheimer's amyloid-beta40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy.
    Bading JR; Yamada S; Mackic JB; Kirkman L; Miller C; Calero M; Ghiso J; Frangione B; Zlokovic BV
    J Drug Target; 2002 Jun; 10(4):359-68. PubMed ID: 12164385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
    Zlokovic BV
    Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid beta in guinea pigs.
    Martel CL; Mackic JB; McComb JG; Ghiso J; Zlokovic BV
    Neurosci Lett; 1996 Mar; 206(2-3):157-60. PubMed ID: 8710175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral beta-amyloid angiopathy in aged squirrel monkeys.
    Elfenbein HA; Rosen RF; Stephens SL; Switzer RC; Smith Y; Pare J; Mehta PD; Warzok R; Walker LC
    Histol Histopathol; 2007 Feb; 22(2):155-67. PubMed ID: 17149688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain.
    Swaminathan SK; Ahlschwede KM; Sarma V; Curran GL; Omtri RS; Decklever T; Lowe VJ; Poduslo JF; Kandimalla KK
    J Cereb Blood Flow Metab; 2018 May; 38(5):904-918. PubMed ID: 28569090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of cerebral beta-amyloid angiopathy.
    Walker LC
    Brain Res Brain Res Rev; 1997 Sep; 25(1):70-84. PubMed ID: 9370051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.
    Goos JD; Teunissen CE; Veerhuis R; Verwey NA; Barkhof F; Blankenstein MA; Scheltens P; van der Flier WM
    Neurobiol Aging; 2012 May; 33(5):1011.e1-9. PubMed ID: 22118945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier transport of circulating Alzheimer's amyloid beta.
    Zlokovic BV; Ghiso J; Mackic JB; McComb JG; Weiss MH; Frangione B
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1034-40. PubMed ID: 8280117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated transport of human amyloid beta-protein 1-40 and 1-42 at the blood-brain barrier.
    Poduslo JF; Curran GL; Sanyal B; Selkoe DJ
    Neurobiol Dis; 1999 Jun; 6(3):190-9. PubMed ID: 10408808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
    Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
    J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
    Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
    Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.
    Merino-Zamorano C; Fernández-de Retana S; Montañola A; Batlle A; Saint-Pol J; Mysiorek C; Gosselet F; Montaner J; Hernández-Guillamon M
    J Alzheimers Dis; 2016 May; 53(2):677-91. PubMed ID: 27232214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
    Saito S; Yamamoto Y; Maki T; Hattori Y; Ito H; Mizuno K; Harada-Shiba M; Kalaria RN; Fukushima M; Takahashi R; Ihara M
    Acta Neuropathol Commun; 2017 Apr; 5(1):26. PubMed ID: 28376923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma.
    Poduslo JF; Curran GL; Kumar A; Frangione B; Soto C
    J Neurobiol; 1999 Jun; 39(3):371-82. PubMed ID: 10363910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys.
    Patel AG; Nehete PN; Krivoshik SR; Pei X; Cho EL; Nehete BP; Ramani MD; Shao Y; Williams LE; Wisniewski T; Scholtzova H
    Brain; 2021 Aug; 144(7):2146-2165. PubMed ID: 34128045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.